[Treatment of venous thromboembolism].

Der Internist
A Willeke, E Lindhoff-Last

Abstract

The main objectives in the treatment of venous thromboembolism are to prevent clot extension and pulmonary embolism, to reduce mortality and to prevent recurrent thromboembolic events as well as postthrombotic disorders. Initial and effective anticoagulation with heparin, preferably with low molecular weight heparin (LMWH), or with fondaparinux is the most important measure. Unfractioned heparin (UFH) is as effective as LMWH, but requires coagulation-monitoring and is associated with a higher risk of heparin-induced thrombocytopenia. In patients with renal insufficiency direct determination of anti-factor Xa activity and dose adjustment is recommended, since drug accumulation can occur over time. In those patients UFH instead of LMWH might be favored. Long-term treatment should be administered with vitamin K-antagonists (INR-target range 2-3) for a duration of 3 to 6 months. In case of recurrent venous thromboembolism, indefinite therapy is recommended. Additional treatment with compression stockings is reasonable. Patients who do not require hospital treatment for other conditions, who have a low bleeding risk, no excessive venous congestion and no symptomatic pulmonary embolism can safely be treated at home. In most cases bed...Continue Reading

References

Nov 19, 1992·The New England Journal of Medicine·D P BrandjesJ W ten Cate
Oct 1, 1990·European Journal of Vascular Surgery·G PlateB Eklöf
Dec 31, 1997·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·G PlateJ A Dahlström
Sep 10, 2002·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·M Elsharawy, E Elzayat
Jun 20, 2003·Circulation·Frederick A Anderson, Frederick A Spencer
Jul 11, 2003·The New England Journal of Medicine·Agnes Y Y LeeUNKNOWN Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Veno
Jun 3, 2004·Annals of Internal Medicine·Harry R BüllerUNKNOWN Matisse Investigators
Jan 25, 2006·Circulation·Nils KucherSamuel Z Goldhaber
Aug 24, 2006·JAMA : the Journal of the American Medical Association·Clive KearonUNKNOWN Fixed-Dose Heparin (FIDO) Investigators
Jul 20, 2007·The Cochrane Database of Systematic Reviews·R OthienoE Okpo
Jan 30, 2009·Journal of Thrombosis and Haemostasis : JTH·E BruinstroopM V Huisman

❮ Previous
Next ❯

Citations

Dec 22, 2009·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·N FeltgenJ Heinz
May 27, 2014·European Journal of Clinical Pharmacology·Kathrin JobskiEdeltraut Garbe
Apr 20, 2018·Operative Orthopädie und Traumatologie·Sebastian AltenbergerMarkus Walther

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

© 2021 Meta ULC. All rights reserved